ACCO
ACCO Brands Corporation
ACCO has the edge over BA overall, supported by stronger valuation and stronger modeled upside.
BA
The Boeing Company
BA has slightly lower modeled downside risk, despite its lower overall score.
ACCO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Weak |
ACCO's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is weak.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
ACCO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.7x | $3.97 | -26% |
| Forward | 5.8x | $5.35 | — |
| Current | 7.6x | $5.35 | — |
| Fair | 8.6x | $6.00 | +12% |
| Expensive | 11x | $8.04 | +50% |
Historical ranges are pointers, not guarantees.
ACCO's PE is in its fair range at 7.6x. If earnings grow as analysts expect, today's price would be 5.8x next year's earnings, in its cheap range.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over ACCO in the historical PE scenario, which offers more potential upside but is not a forecast.
ACCO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for ACCO, with profitability holding steady.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
BA has the edge over ACCO on the outlook, with more favorable profitability expectations.
ACCO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.92 | +31% |
| Q3 2026 | $0.70 | +67% |
| Q2 2026 | $0.62 | +32% |
| Q1 2026 | $0.78 | +$1.91 |
| Q4 2025 | $0.44 | +$1.50 |
| Q3 2025 | $0.42 | +$2.30 |
| Q2 2025 | $0.47 | +$2.29 |
| Q1 2025 | -$1.13 | -$0.87 |
| Q4 2024 | -$1.06 | -$0.83 |
ACCO has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
ACCO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $380.3M | -0.9% |
| Q2 2026 | $415.1M | +5.1% |
| Q1 2026 | $343.7M | +8.3% |
| Q4 2025 | $428.8M | -4.3% |
| Q3 2025 | $383.7M | -8.8% |
| Q2 2025 | $394.8M | -9.9% |
| Q1 2025 | $317.4M | -12% |
| Q4 2024 | $448.1M | -8.3% |
ACCO's revenue fell from its 2021 peak and has held roughly level since: $380M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8% | +1.2 points |
| Q2 2026 | 7.3% | -1.1 points |
| Q1 2026 | -3% | -0.9 points |
| Q4 2025 | 9.3% | 0 points |
| Q3 2025 | 6.8% | +0.5 points |
| Q2 2025 | 8.4% | +34 points |
| Q1 2025 | -2.1% | -3.8 points |
| Q4 2024 | 9.4% | +20 points |
ACCO has the edge over BA on profitability, with a higher operating margin.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over ACCO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
ACCO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $131.4M | +84% |
| Q2 2026 | -$35.3M | +$3.6M |
| Q1 2026 | $3.5M | -36% |
| Q4 2025 | $30.6M | -42% |
| Q3 2025 | $71.5M | -23% |
| Q2 2025 | -$38.9M | -$13.3M |
| Q1 2025 | $5.5M | -80% |
| Q4 2024 | $52.7M | -9.1% |
ACCO generated $130M in free cash flow over the past year, up 43% from the year before.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over ACCO on cash flow, with more consistent year-over-year improvement.
ACCO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.5x | High |
| Q2 2026 | 5.3x | High |
| Q1 2026 | 4.9x | High |
| Q4 2025 | 4.7x | High |
| Q3 2025 | 4.7x | High |
| Q2 2025 | 5.1x | High |
| Q1 2025 | 33.9x | High |
| Q4 2024 | 21.1x | High |
ACCO's net debt is about 4.5 years of its operating earnings (EBITDA), down from 4.7 years a year ago.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA has the edge over ACCO on leverage, with a lower net debt burden relative to earnings.
ACCO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.3 | Neutral |
| Stochastic | 75.7 | Neutral |
ACCO's weekly RSI is 67 (neutral) and its Stochastic is 76 (neutral).
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
ACCO PE vs Industrials Sector
| Metric | ACCO | Sector median | Relative |
|---|---|---|---|
| PE | 7.6x | 24x | 68% below |
| PE % | 39 | 58 | 19 pts below |
ACCO has the edge over BA on valuation relative to its sector.
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
ACCO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.76 | 12% above |
| 20 week MA | $4.43 | 21% above |
| 50 week MA | $4.01 | 33% above |
| 100 week MA | $4.06 | 32% above |
| 200 week MA | $4.72 | 13% above |
ACCO has the edge over BA on trend strength, trading above more of its moving averages.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
ACCO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.34 | $8.53 | -8.7% |
| 2021 | $8.53 | $8.05 | -5.6% |
| 2022 | $8.05 | $5.58 | -31% |
| 2023 | $5.58 | $6.08 | +9% |
| 2024 | $6.08 | $5.25 | -14% |
| 2025 | $5.25 | $3.73 | -29% |
| 2026 YTD | $3.73 | $5.35 | +43% |
ACCO has the edge over BA on returns for 2026, with the stronger performance.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.